Recombinant Human KDM6A Protein，His

KDM6A (Lysine Demethylase 6A) is a member of the KDM6 family of histone demethylases, which play a crucial role in epigenetic regulation by removing methyl groups from histone lysine residues. This action can lead to the activation or repression of gene expression, impacting various biological processes including development, differentiation, and cell identity. Recent studies have highlighted the importance of KDM6A in various diseases, particularly in cancer, where mutations or dysregulation of this protein have been implicated in tumorigenesis and poor prognosis. The enzyme primarily removes methylation marks from histone H3 at lysine 27, a modification often associated with gene silencing. Investigating KDM6A has gained significance as it has shown potential as a therapeutic target, with compounds developed to inhibit its demethylase activity at the forefront of cancer research. Moreover, KDM6A is involved in processes such as stem cell maintenance and immune response, making it a critical protein for understanding both normal biological functions and pathological conditions. The study of KDM6A and its recombinant forms is essential for elucidating its mechanisms of action and discovering novel therapeutic strategies to combat diseases linked to its dysfunction. This background sets the stage for further exploration of KDM6A in basic research and clinical applications, ultimately aiming to enhance our understanding of epigenetic regulation in health and disease.